Thakur Raghu Raj Singh

    Thakur Raghu Raj Singh

    Senior Lecturer

    Phone: +44 (0)28 9097 5814, +44 (0)28 9097 2719

    For media contact email comms.office@qub.ac.uk
    or call +44(0)2890 973091.

    View graph of relations

    Research Interests

    Dr Thakur Raghu Raj Singh is Senior Lecturer in Pharmaceutics in the School of Pharmacy, Queen's University Belfast. He has obtained his PhD in Drug Delivery from School of Pharmacy, Queens University Belfast (2009), M.Sc in Pharmaceutical Sciences from University Science Malaysia (2006) and B.Pharm from Jawaharlal Nehru Technological University, India (2002).

    Dr Thakur’s research interests are in the design and physicochemical characterisation of advanced polymeric drug delivery systems for ocular, transdermal and topical applications. In particular, his current research involves the fabrication and design of novel long-acting injectable and implantable drug delivery systems for treating back of the eye disorders. Dr Thakur's ocular drug delivery research has lead to the formation of Re-Vana Therapeutics Ltd. He is currently acting as the CSO for Re-Vana.

    He is Vice-Chair for Ocular Delivery (OcD) Focus Group supported by the mission of Controlled Release Society (CRS) that engages researchers, industry representatives, and regulatory experts in the advancement of technologies designed to protect or restore vision

    He has authored over 132 scientific publications, including 50 peer-reviewed research papers, 10 book chapters and 4 textbooks. He has been an invited speaker at a number of national/international meetings. He is currently Editorial Board member of the International Journal of Pharmacy & Pharmacology, Chronicles of Pharmacy and SCIENCEDOMAIN international, and Scientific advisor for Journal of Pharmaceutical Sciences. He is a reviewer for several high impact journals.  

    Willingness to take PhD students

    Yes

    PhD projects

    Open to PhD applications in the field of small and large molecule delivery using novel platforms such as injectable implants, micro-/nanoparticle, microneedles, and medical devices for ocular and transdermal applications.

    Frequent Journals

    View all »

    View all

    Contribution to conference papers, events and activities

    ID: 53920